How is MYX going to differentiate itself. It is a pill reseller with a couple of protected products, which they had to pay the right to sell.
They will never succeed by inventing product, so they are just a pill seller. If they can do it well and get good margins, by using the method they have set up for dermatology with other areas of medicine, they may just end up successful. BUT they don't have a unique product. All we can hope for is that the branded products can be very profitable while protected over the next 5 years.
Ann: Mayne Pharma completes sale of Metrics Contract Services, page-82
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.81 |
Change
0.430(9.82%) |
Mkt cap ! $409.2M | |||
| Open | High | Low | Value | Volume |
| $4.44 | $4.81 | $4.44 | $1.701M | 362.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 115 | $4.79 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.81 | 6332 | 3 |
View Market Depth
| Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
| MYX (ASX) Chart |